SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002543
Filing Date
2024-01-05
Accepted
2024-01-05 17:26:57
Documents
14
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20240105.htm   iXBRL 8-K 50344
2 EX-1.1 olma-ex1_1.htm EX-1.1 363615
3 EX-5.1 olma-ex5_1.htm EX-5.1 24326
  Complete submission text file 0000950170-24-002543.txt   620844

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT olma-20240105.xsd EX-101.SCH 2448
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT olma-20240105_lab.xml EX-101.LAB 13466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT olma-20240105_pre.xml EX-101.PRE 9886
8 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240105_htm.xml XML 4760
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 24517592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)